234 related articles for article (PubMed ID: 25836963)
1. A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).
Casey W; Jacobs A; Maull E; Matheson J; Clarke C; Lowit A
J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):170-3. PubMed ID: 25836963
[TBL] [Abstract][Full Text] [Related]
2. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
Stokes WS; Schechtman LM; Hill RN
Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
[TBL] [Abstract][Full Text] [Related]
3. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
Schechtman LM
ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
[TBL] [Abstract][Full Text] [Related]
4. ECVAM-ICCVAM: prospects for future collaboration.
Schechtman LM; Stokes WS
Altern Lab Anim; 2002 Dec; 30 Suppl 2():227-36. PubMed ID: 12513682
[TBL] [Abstract][Full Text] [Related]
5. The FDA's regulatory role in the ICCVAM process.
Schechtman LM; Stokes WS
Altern Lab Anim; 2004 Jun; 32 Suppl 1B():663-8. PubMed ID: 23581155
[TBL] [Abstract][Full Text] [Related]
6. ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process.
Sailstad DM; Hattan D; Hill RN; Stokes WS
Regul Toxicol Pharmacol; 2001 Dec; 34(3):249-57. PubMed ID: 11754529
[TBL] [Abstract][Full Text] [Related]
7. Validating new toxicology tests for regulatory acceptance.
Zeiger E; Stokes WS
Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):32-7. PubMed ID: 9629594
[TBL] [Abstract][Full Text] [Related]
8. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.
Corvi R; Ahr HJ; Albertini S; Blakey DH; Clerici L; Coecke S; Douglas GR; Gribaldo L; Groten JP; Haase B; Hamernik K; Hartung T; Inoue T; Indans I; Maurici D; Orphanides G; Rembges D; Sansone SA; Snape JR; Toda E; Tong W; van Delft JH; Weis B; Schechtman LM
Environ Health Perspect; 2006 Mar; 114(3):420-9. PubMed ID: 16507466
[TBL] [Abstract][Full Text] [Related]
9. International Harmonization and Cooperation in the Validation of Alternative Methods.
Barroso J; Ahn IY; Caldeira C; Carmichael PL; Casey W; Coecke S; Curren R; Desprez B; Eskes C; Griesinger C; Guo J; Hill E; Roi AJ; Kojima H; Li J; Lim CH; Moura W; Nishikawa A; Park H; Peng S; Presgrave O; Singer T; Sohn SJ; Westmoreland C; Whelan M; Yang X; Yang Y; Zuang V
Adv Exp Med Biol; 2016; 856():343-386. PubMed ID: 27671730
[TBL] [Abstract][Full Text] [Related]
10. National Institute of Environmental Health Sciences (NIEHS); the Murine Local Lymph Node Assay: a Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds, report now available. Public Health Service.
Fed Regist; 1999 Mar; 64(55):14006-7. PubMed ID: 10558409
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Development and Validation of Test Methods in the United States.
Casey WM
Toxicol Res; 2016 Jan; 32(1):9-14. PubMed ID: 26977254
[TBL] [Abstract][Full Text] [Related]
12. Validation and regulatory acceptance of alternatives.
Hill RN; Stokes WS
Camb Q Healthc Ethics; 1999; 8(1):73-9. PubMed ID: 9924621
[No Abstract] [Full Text] [Related]
13. Alternatives to animal testing: information resources via the Internet and World Wide Web.
Hakkinen PJ; Green DK
Toxicology; 2002 Apr; 173(1-2):3-11. PubMed ID: 11955681
[TBL] [Abstract][Full Text] [Related]
14. Validating new toxicology tests for regulatory acceptance.
Zeiger E; Stokes WS
Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 2):32-7. PubMed ID: 9618321
[TBL] [Abstract][Full Text] [Related]
15. [Validation and regulatory acceptance of alternative methods for toxicity evaluation].
Ohno Y
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2004; (122):1-9. PubMed ID: 15940895
[TBL] [Abstract][Full Text] [Related]
16. United States regulatory requirements for skin and eye irritation testing.
Choksi NY; Truax J; Layton A; Matheson J; Mattie D; Varney T; Tao J; Yozzo K; McDougal AJ; Merrill J; Lowther D; Barroso J; Linke B; Casey W; Allen D
Cutan Ocul Toxicol; 2019 Jun; 38(2):141-155. PubMed ID: 30418044
[TBL] [Abstract][Full Text] [Related]
17. Skin sensitization testing needs and data uses by US regulatory and research agencies.
Strickland J; Daniel AB; Allen D; Aguila C; Ahir S; Bancos S; Craig E; Germolec D; Ghosh C; Hudson NL; Jacobs A; Lehmann DM; Matheson J; Reinke EN; Sadrieh N; Vukmanovic S; Kleinstreuer N
Arch Toxicol; 2019 Feb; 93(2):273-291. PubMed ID: 30377734
[TBL] [Abstract][Full Text] [Related]
18. Predictive Models for Acute Oral Systemic Toxicity: A Workshop to Bridge the Gap from Research to Regulation.
Kleinstreuer NC; Karmaus A; Mansouri K; Allen DG; Fitzpatrick JM; Patlewicz G
Comput Toxicol; 2018 Nov; 8(11):21-24. PubMed ID: 30320239
[TBL] [Abstract][Full Text] [Related]
19. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
[TBL] [Abstract][Full Text] [Related]
20. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
Haneke KE; Tice RR; Carson BL; Margolin BH; Stokes WS
Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]